spacer
home > ebr > summer 2004 > editor's letter
PUBLICATIONS
European Biopharmaceutical Review

Editor's Letter

As we bring you the summer issue of EBR, there appear to be guarded grounds for continued optimism towards an upswing in the European biotechnology industry. As evidenced by the upbeat mood of the US industry at the recent Annual BIO Convention, this new optimism seems to be based on tangible measures of an industry regaining its feet. For example, increasing numbers of biologic drugs (25 out of 37) approved by the FDA in 2003, coupled to decreasing product review timeframes by the FDA, led to renewed investor interest and the second most successful financing year in the US industry's history in 2003 ($19 billion in public and private funds). However, the situation in Europe isn't quite that rosy.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Technology Consultant at London Technology Network
spacer
Dr Helen Abbott
spacer
spacer
spacer
Lucy George
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

April 1, 2020 Ė ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits. ERTís At-Home Respiratory Solutions enable clinical trial sponsors to continue developing new respiratory treatments while patient access to investigative sites is limited due to COVID19 stay-at-home mandates.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement